Analyst Price Targets — MD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 11:48 am | — | Truist Financial | $28.00 | $26.14 | TheFly | Pediatrix Medical price target raised to $28 from $23 at Truist |
| May 12, 2026 12:58 pm | — | UBS | $25.00 | $23.42 | TheFly | Pediatrix Medical price target raised to $25 from $22 at UBS |
| May 8, 2026 11:19 am | — | Mizuho Securities | $24.00 | $22.93 | TheFly | Pediatrix Medical price target raised to $24 from $21 at Mizuho |
| April 20, 2026 4:54 pm | Jack Slevin | Jefferies | $27.00 | $23.22 | TheFly | Pediatrix Medical price target raised to $27 from $24 at Jefferies |
| February 24, 2026 12:59 pm | — | UBS | $22.00 | $19.20 | TheFly | Pediatrix Medical price target lowered to $22 from $23 at UBS |
| February 20, 2026 1:32 pm | — | Deutsche Bank | $19.00 | $18.80 | TheFly | Pediatrix Medical price target lowered to $19 from $21 at Deutsche Bank |
| February 19, 2026 6:04 pm | — | Truist Financial | $21.00 | $18.41 | TheFly | Pediatrix Medical price target lowered to $21 from $24 at Truist |
| November 10, 2025 3:04 pm | David MacDonald | Truist Financial | $24.00 | $22.30 | TheFly | Pediatrix Medical price target raised to $24 from $17 at Truist |
| November 5, 2025 2:27 pm | — | UBS | $23.00 | $21.46 | TheFly | Pediatrix Medical price target raised to $23 from $16.50 at UBS |
| October 14, 2025 1:22 pm | David MacDonald | Truist Financial | $17.00 | $16.04 | TheFly | Pediatrix Medical price target raised to $17 from $16 at Truist |
Latest News for MD
Shares of Pediatrix Medical Group, Inc. (NYSE: MD - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year
Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group, Inc. (NYSE: MD) (“Pediatrix” or “the Company”), a leading provider of physician services, today provided an update on its second quarter 2026 business trends. In response to recent reports from other healthcare market participants regarding shifting utilization and reimbursement trends, the Company confirms that its payor mix for the second…
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.